May 5th, 2014
William Boden and PK Shah discuss the CHI-SQUARE trial, which failed to show a benefit for an HDL mimetic.
January 27th, 2014
William E. Boden discusses his research group’s post hoc analysis of data from the COURAGE trial.
January 9th, 2013
William E. Boden, lead investigator of the AIM-HIGH trial, and CardioExchange’s Harlan M. Krumholz debate the current state of research on niacin therapy.
January 4th, 2013
In the wake of HPS2-THRIVE, John Ryan asks William E. Boden, lead investigator of the AIM-HIGH trial, for his perspective on niacin and other HDL-modifying therapies.